Transcends the intellectual-divide with Key Facts (areas of focus explained for the lay person), Definitions Of Words And Terms, and Summary Points.
Wide applicability with each chapter containing a section called Potential Applications To Prognosis, Other Diseases Or Conditions.
Authoritative text by leading experts.
Links conventional approaches with new platforms.
Holistic coverage of material with over 40 chapters.
Transcends the intellectual-divide with Key Facts (areas of focus explained for the lay person), Definitions Of Words And Terms, and Summary Points.
Wide applicability with each chapter containing a section called Potential Applications To Prognosis, Other Diseases Or Conditions.
Authoritative text by leading experts.
Links conventional approaches with new platforms.
Holistic coverage of material with over 40 chapters.
Includes supplementary material: sn.pub/extras
Professor Victor R. Preedy is a senior faculty member of King's College London (Professor of Nutritional Biochemistry) and King's College Hospital (Professor of Clinical Biochemistry). He is attached to both the Diabetes and Nutritional Sciences Division and the Department of Nutrition and Dietetics. He is also Director of the Genomics Centre and a member of the School of Medicine. Professor Preedy graduated in 1974 with an Honours Degree in Biology and Physiology with Pharmacology. He gained his University of London PhD in 1981. In 1993 he gained his second doctoral degree, for his outstanding contribution to protein metabolism in health and disease. He has received membership and fellowship of a number of academic and professional bodies in the UK, including the Royal College of Pathologists, the Royal Institute of Public Health, and the Royal Society of Chemistry. Professor Preedy has published over 570 articles, which includes 165 peer-reviewed manuillegalscripts based on original research, 100 reviews, and over 50 books and book volumes.
The World Health Organisation have reported that each year on a global basis there are over 8 million deaths from cancer. This is 13% of all deaths. As well as those who die, there are many who are being treated for cancer. Some cancers, hitherto deemed to be incurable, can now be cured. Part of the overall package of healthcare related to cancer is the application of biomarkers. Biomarkers can be used not only to determine stages and effects of cancer, but also to aid treatments regimes.
Biomarkers in Cancer combines detailed information on cancer types and the use of biological indicators. It covers the latest knowledge, trends and applications. It links conventional approaches with new platforms
Biomarkers in Metastatic Colorectal Cancer.- CD163 and TARC as Disease Response Biomarkers in Hodgkin Lymphoma.- Expression Profiling as Biomarkers in Colorectal Serrated Adenocarcinoma.- Immunophenotypiing as Biomarker Platform in Leukemia.- Matrix metalloproteinase family as molecular biomarkers in oral tongue cancers.- Microarrays and Renal Cell Cancer Biomarkers.- Telomerase as Biomarker for Oral Cancer.- Telomerase as Biomarker in Colorectal Cancer.- U2 Small Nuclear RNA as Biomarker in Cancer.- Whole Blood Tranillegalscriptome as Biomarkers in Nasopharyngeal Cancer.
The World Health Organisation have reported that each year on a global basis there are over 8 million deaths from cancer. Part of the overall package of healthcare related to cancer is the application of biomarkers. Biomarkers can be used not only to determine stages and effects of cancer, but also to aid treatments regimes.
The World Health Organisation have reported that each year on a global basis there are over 8 million deaths from cancer. This is 13% of all deaths. As well as those who die, there are many who are being treated for cancer. Some cancers, hitherto deemed to be incurable, can now be cured. Part of the overall package of healthcare related to cancer is the application of biomarkers. Biomarkers can be used not only to determine stages and effects of cancer, but also to aid treatments regimes.
Biomarkers in Cancer combines detailed information on cancer types and the use of biological indicators. It covers the latest knowledge, trends and applications. It links conventional approaches with new platforms
Professor Victor R. Preedy is a senior faculty member of King's College London (Professor of Nutritional Biochemistry) and King's College Hospital (Professor of Clinical Biochemistry). He is attached to both the Diabetes and Nutritional Sciences Division and the Department of Nutrition and Dietetics. He is also Director of the Genomics Centre and a member of the School of Medicine. Professor Preedy graduated in 1974 with an Honours Degree in Biology and Physiology with Pharmacology. He gained his University of London PhD in 1981. In 1993 he gained his second doctoral degree, for his outstanding contribution to protein metabolism in health and disease. He has received membership and fellowship of a number of academic and professional bodies in the UK, including the Royal College of Pathologists, the Royal Institute of Public Health, and the Royal Society of Chemistry. Professor Preedy has published over 570 articles, which includes 165 peer-reviewed manuillegalscripts based on original research, 100 reviews, and over 50 books and book volumes.
Inhaltsverzeichnis
Biomarkers in Metastatic Colorectal Cancer.- CD163 and TARC as Disease Response Biomarkers in Hodgkin Lymphoma.- Expression Profiling as Biomarkers in Colorectal Serrated Adenocarcinoma.- Immunophenotypiing as Biomarker Platform in Leukemia.- Matrix metalloproteinase family as molecular biomarkers in oral tongue cancers.- Microarrays and Renal Cell Cancer Biomarkers.- Telomerase as Biomarker for Oral Cancer.- Telomerase as Biomarker in Colorectal Cancer.- U2 Small Nuclear RNA as Biomarker in Cancer.- Whole Blood Tranillegalscriptome as Biomarkers in Nasopharyngeal Cancer.
Klappentext
The World Health Organisation have reported that each year on a global basis there are over 8 million deaths from cancer. This is 13% of all deaths. As well as those who die, there are many who are being treated for cancer. Some cancers, hitherto deemed to be incurable, can now be cured. Part of the overall package of healthcare related to cancer is the application of biomarkers. Biomarkers can be used not only to determine stages and effects of cancer, but also to aid treatments regimes. Biomarkers in Cancer combines detailed information on cancer types and the use of biological indicators. It covers the latest knowledge, trends and applications. It links conventional approaches with new platforms
Title is also available as part of a set: Biomarkers in Cancer (978-94-007-7682-1)
